Your browser doesn't support javascript.
loading
Safety and efficacy of the maximum tolerated dose of givinostat in polycythemia vera: a two-part Phase Ib/II study.
Rambaldi, Alessandro; Iurlo, Alessandra; Vannucchi, Alessandro M; Noble, Richard; von Bubnoff, Nikolas; Guarini, Attilio; Martino, Bruno; Pezzutto, Antonio; Carli, Giuseppe; De Muro, Marianna; Luciani, Stefania; McMullin, Mary Frances; Cambier, Nathalie; Marolleau, Jean-Pierre; Mesa, Ruben A; Tibes, Raoul; Pancrazzi, Alessandro; Gesullo, Francesca; Bettica, Paolo; Manzoni, Sara; Di Tollo, Silvia.
Afiliación
  • Rambaldi A; Department of Oncology and Hematology, University of Milan and ASST Papa Giovanni XXIII, Bergamo, Italy. alessandro.rambaldi@unimi.it.
  • Iurlo A; Hematology Division, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Vannucchi AM; Department of Experimental and Clinical Medicine, University of Florence, Azienda Ospedaliera-Universitaria Careggi, Florence, Italy.
  • Noble R; Department of Hematology, Royal Cornwall Hospital, Truro, UK.
  • von Bubnoff N; Department of Hematology, Oncology and Stem Cell Transplantation, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Guarini A; Department of Hematology and Oncology, Medical Center, University of Schleswig-Holstein, Campus Lübeck, Lübeck, Germany.
  • Martino B; Hematology Unit, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
  • Pezzutto A; Oncology-Hematology Department, A.O. "Bianchi-Melacrino-Morelli", Reggio Calabria, Italy.
  • Carli G; Department of Hematology Oncology, Charité' Medical School, Campus Benjamin Franklin, Berlin, Germany.
  • De Muro M; U.O. Hematology, San Bortolo Hospital, Vicenza, Italy.
  • Luciani S; Hematology and Stem Cells Transplantation Unit, Campus Bio-Medico, University Hospital, Rome, Italy.
  • McMullin MF; U.O. Clinical Hematology, Presidio Ospedaliero "Spirito Santo"-A.S.L. Azienda Sanitaria Locale, Pescara, Italy.
  • Cambier N; Centre for Medical Education, Queen's University Belfast, Belfast, UK.
  • Marolleau JP; Service d'Oncologie Hématologie, Hospital Saint Vincent de Paul-GHICL Lille, Lille, France.
  • Mesa RA; Service d'Oncologie Hématologie Clinique, CHU Amiens-Hospital Sud, Amiens, France.
  • Tibes R; Mayo Clinic Cancer Center, Scottsdale, AZ, USA.
  • Pancrazzi A; New York University School of Medicine & Perlmutter Cancer Center/ NYU Langone Health, New York, NY, USA.
  • Gesullo F; Department of Experimental and Clinical Medicine, University of Florence, Azienda Ospedaliera-Universitaria Careggi, Florence, Italy.
  • Bettica P; Department of Experimental and Clinical Medicine, University of Florence, Azienda Ospedaliera-Universitaria Careggi, Florence, Italy.
  • Manzoni S; Clinical R&D Department, Italfarmaco S.p.A., Cinisello Balsamo, Italy.
  • Di Tollo S; Clinical R&D Department, Italfarmaco S.p.A., Cinisello Balsamo, Italy.
Leukemia ; 34(8): 2234-2237, 2020 08.
Article en En | MEDLINE | ID: mdl-32047238

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Policitemia Vera / Carbamatos Tipo de estudio: Clinical_trials Aspecto: Patient_preference Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Policitemia Vera / Carbamatos Tipo de estudio: Clinical_trials Aspecto: Patient_preference Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Italia